HomeMarketsSharesCaixaBank, S.A.

Trade CaixaBank, S.A. - CABK CFD

Market is not available at the momentMarket information is presented
as of 2026-10-08T15:26:06+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.04
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.018013 %
(-€3.60)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.01801%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
€1,000.00
Overnight funding adjustment
Charges from full value of position
-0.004209 %
(-€0.84)

Trade size with leverage ~ €20,000.00

Money from leverage ~ $€19,000.00


-0.00421%
Overnight funding adjustment time21:00 (UTC)
CurrencyEUR
Min traded quantity1
Margin5.00%
Stock exchangeSpain
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close11.89
Open11.71
1-Year Change31.28%
Day's Range11.69 - 11.99

Trade CaixaBank, S.A. - CABK

About CaixaBank SA

Caixabank SA is a Spain-based bank. Its activities are divided into two business segments: Banking and insurance, as well as Investments. The Banking and insurance division provides financial services for individual customers, including retail, private and personal banking, business customers, such as commercial and corporate banking, cash management and markets solutions, as well as offers insurance products. The Investments division includes investments in the international banking investee portfolio, as well as stakes in other companies, such as Repsol SA and Telefonica SA. The Bank operates through domestic and foreign branches, as well as representative offices in Europe, the Americas, Africa and Asia. It is a subsidiary of Criteria Caixa SA.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, CaixaBank SA interest income increased 17% to EUR7.89B. Net interest income after loan loss provision increased 21% to EUR5.08B. Net income applicable to common stockholders excluding extraordinary items increased from EUR1.24B to EUR4.98B. Net interest income after loan loss provision reflects Banking and Insurance segment increase of 23% to EUR5.56B, BPI segment increase of 2% to EUR453M.

Equity composition

9/2015, Scrip Issue, 1 new share for every 95 shares held (Factor: 1.00966). 10/2013, Scrip Issue, 1 new share for every 65 shares held (Factor:1.01538). 11/2013, Scrip Issue, 1 new share for every 69 shares held (Factor: 1.0135). 3/2016, Scrip Issue, 1 new share for every 63 shares held (Factor:1.01587 changed to 1.01481 on 3/23/2016)

Latest shares articles

CaixaBank stock forecast
CaixaBank stock forecast: BPI exits Angola market
CaixaBank is a Spanish bank whose Portuguese unit, Banco BPI, agreed to sell its 33.35% stake in Banco de Fomento de Angola for €388.5m. Explore third-party CABK price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:00, 5 October 2026
A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
12:41, 7 October 2026
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:18, 7 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready